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A biologic role of HIF-1 in the renal medulla.
Background. Activation of hypoxia-inducible factor-1 (HIF-
1) is the primary defensive mechanism against hypoxia. HIF-1
activation generally occurs in pathologic disruption of tissue
oxygenation. However, a biologic role of HIF-1 in the medulla
of the kidney, which is considered perpetually hypoxic under
physiologic conditions due to its unique circulation, remains to
be elucidated.
Methods. The expression of HIF-1a was detected by immuno-
histochemical analysis. Functional studies of HIF in medulla
were carried out by gene transfer of various plasmids by retro-
grade injection via ureter.
Results. Our immunohistochemical analysis detected HIF-
1a in the inner stripe and the inner medulla of normal rats.
Water deprivation increased the number of HIF-1a–positive
cells, which may be mediated by an increase in medullar work-
load and a decrease in local blood flow. To perform functional
studies, we performed gene transfer. Efficient expression of
the transgene was confirmed using an enhanced green fluo-
rescent protein (E-GFP) expressing vector. Our histologic and
immunoblotting analysis detected the transgene product at the
inner medulla and the inner stripe 48 hours after injection. Ad-
ministration of negative-dominant HIF induced severe damage
in the medulla of normal rats. In contrast, gene transfer of con-
stitutively active HIF (HIF/VP16) induced expression of var-
ious HIF-regulated genes and protected the medulla against
ischemic insults.
Conclusion. Our studies demonstrated a crucial role of HIF
in the renal medulla under normal and hypoxic circumstances.
Oxygen acts as the terminal electron transporter in
oxidative phosphorylation of aerobic respiration. Inad-
equate oxygen supply is the oldest insult for all aerobic
organisms since the early days of evolution. Even these
days, acute tissue hypoxia is the elemental basis of many
human fatal diseases, including stroke and myocardial in-
farction [1]. In contrast, accumulating evidence suggests
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that chronic tissue hypoxia is involved in the pathophys-
iology of several diseases, including kidney failure [2–5].
During evolution, vertebrates have developed an
oxygen-sensing pathway which can rapidly detect in-
adequate oxygen states and robustly transcribe a large
group of genes which are involved in multiple adaptive
responses. All these genes are regulated mainly by
oxygen-sensitive heterodimeric basic helix-loop-helix
and Per-Arnt-Sim (PAS) motif transcriptional factor,
hypoxia-inducible factor-1 (HIF-1), which serves as a pri-
mary oxygen sensor [1, 6]. HIF-1 consists of two subunits.
Oxygen-insensitive beta subunit (HIF-1b) is constitu-
tionally expressed and does not play a direct regulatory
role. In contrast, alpha subunit (HIF-1a) is constitution-
ally transcribed but rapidly degraded in the presence of
oxygen, functioning as an oxygen-sensing and regulatory
subunit [7, 8]. Oxygen-dependent hydroxylation by pro-
lylhydroxylase enzymes, at proline residues (Pro402 and
Pro564) of HIF-1a, regulates the degradation via von
Hipple-Lindau adaptor and polyubiquitination pathway
[9–14], and the degradation rate is declined in hypoxic
states, leading to accumulation HIF-1a and consequently
its dimerization with HIF-1b . Oxygen also regulates ac-
tivity of HIF-1a via hydroxylation at asparagine (Asn
803) of the transactivation domain [15]. Moreover, nu-
clear translocation of HIF-1a also depends on oxygen
through the poorly understood mechanisms [16].
Thus, the HIF pathway allows sufficient oxygenation of
mammalian tissues. However, because of its unique coun-
tercurrent capillary network and extremely low blood
flow [17–20], renal medulla, which plays a major role
in water conservation, is permanently hypoxic. Tissue
oxygen in the renal medulla becomes even less when
medullary workload is increased [17, 20, 21]. The mech-
anism(s) how medulla adapts to the unphysiologic en-
vironment has always been a subject of interest [17, 18,
21–23]. Understanding functions of HIF-1 in this area will
give us important insight about natural hypoxic adapta-
tion, which may turn to be useful to develop therapeutic
tools against ischemia.
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METHODS
Animal
Male Sprague-Dawley rats weighing 250 g were
purchased from Nippon Seibutsu Zairyo Center Co.
(Saitama, Japan). They were housed in a temperature
controlled facility with 12-hour light on, 12-hour light off,
free access to diet and water. Only in water-deprivation
studies, animals were obligated to water. All animal stud-
ies were conformed to the principles of the Guide for
Animal Experimentation at University of Tokyo.
Antibodies
Polyclonal rabbit antienhanced green fluorescent pro-
tein (E-GFP) antibody (1:500) (MBL, Nagoya, Japan),
monoclonal mouse antihuman HIF-1a antibody (1:100)
(Novus Biological, Littleton, CO, USA), monoclonal
mouse antirat endothelium antibody JG12 (1:50) (Ben-
der Medsystems, Vienna, Austria), monoclonal mouse
antirat macrophage antibody ED1 (1:400) (Chemicon,
Temecula, CA, USA), polyclonal rabbit antinitrotyrosine
antibody (1:300) (Sigma Chemical Co., St. Louis, MO,
USA), polyclonal rabbit antihuman vascular endothe-
lial growth factor (VEGF) antibody (1:500) (Santa Cruz
biotechnology, Santa Cruz, CA, USA), biotinylated anti-
mouse immunoglobulin antibody (1:400) (Vector Labo-
ratories, Burlingame, CA, USA), biotinylated antirabbit
immunoglobulin antibody (1:400) (Vector Laboratories)
and avidin-conjugated horseradish peroxidase (1:1000)
(Vector Laboratories) were used in this study at the indi-
cated dilutions.
Plasmids
Mammalian expression plasmid encoding E-GFP un-
der the CAG promoter, HIF 1-396/VP16 encoding basic
helix-loop-helix (bHLH) and PAS domain of the first 396
AA of human HIF-1a fused with trans-activation domain
of herpes virus [24], E-GFP/HIF-1a/K719T encoding E-
GFP fused with a full length of human HIF-1a with a
targeted mutation at the functioning nuclear localization
signal (NLS) motif 719 AAG → AAT [16], and HIF-1-330
encoding the first 330 AA of human HIF-1a [25], were
used in this study. All plasmids were transformed into
competent cells, JM109 (Toyobo, Osaka, Japan). Large-
scale plasmids were purified with Qiagen Plasmid Maxi
Kits (Qiagen Inc., Valencia, CA, USA) according to the
manufacturer’s protocol.
Transureter medullary gene transfer
Twenty-five micrograms of plasmid DNA were dis-
solved in 100 lL TE pH 8.0, then stored at −20◦C until
use. At the experimental day, a stock plasmid was thawed,
mixed with 10 lL Lipofectamine (Gibco, Grand island,
NY, USA), and left at room temperature for 40 min-
utes. Then, plasmid was diluted with sterile phosphate-
buffered saline (PBS) to final volume 0.5 mL before trans-
fer. Left ureter was exposed by midline incision, which
then were cannulated with 24 G needle (Terumo, Tokyo,
Japan) at middle portion. Two hundred microliters of PBS
was retrograde flushed to kidney [26]. After draining PBS,
plasmid solution was injected in 30 seconds, the pressure
was held for 30 seconds, then the catheter was removed.
Puncture tear was sealed with fascia flap.
Total RNA isolation and real-time quantitative
polymerase chain reaction (PCR)
Total RNA from medullary tissues of each rat was iso-
lated with Isogen according to the manufacturer’s proto-
col (Wako Chemical, Osaka, Japan). cDNA synthesis was
carried out with 2 lg of isolated RNA at 42◦C for 1 hour
with an Oligo-dT Inpromp-II Kit (Promega, Madison,
WI, USA). One microgram of cDNA was subjected to
real-time PCR (iCycler iQTM) (Bio-Rad, Hercules, CA,
USA) utilizing Syber Green Supermix (Bio-Rad) with
the corresponding primers as follows: b-actin 5′-CTTT
CTACAATGAGCTGCGTG-3′, 5′-TCATGAGGTAG
TCTGTCAGG-3′; erythopoietin (EPO) 5′-TACGTAGC
CTCACTTCACTGCTT-3′, 5′-GCAGAAAGTATCCG
CTGTGAGTGTTC-3′; glucose transporter-1 (GLUT-1)
5′-CAGTTCGGCTATAACACCGGTGTC-3′, 5′-ATA
GCGGTGGTTCCATGTTT-3′; heme oxygenase-1
(HO-1) 5′-TCTATCGTGCTCGCATGAAC-3′, 5′-CAG
CTCCTCAAACAGCTCAA -3′, and VEGF 5′-TTAC
TGCTGTACCTCCAC-3′, 5′-ACAGGACGGCTTGA
AGATA-3′ [27]. The PCR was amplified for 40 cycles.
Each PCR product was subjected to melting curve
analysis after PCR was completed. Threshold cycles for
each primer were separately analyzed. The amounts of
target mRNA/b-actin mRNA were calculated according
to the following equation: target mRNA/b-actin mRNA
= 2−(tc−bc) where tc and bc are the threshold cycles
of the target gene and b-actin, respectively. The ratios
compared to the data of the medullary tissues of normal
rats were estimated, and reproducibility was confirmed
in three independent experiments, with representative
data presented in Results section.
For detection of HIF/VP16, a forward primer was de-
signed to match human HIF-1a 5′-GCTTGGTGCTGA
TTTGTGAACC-3′ while a backward primer was
designed for transactivation domain of herpes virus
(HSV1), 5′-GGGCATCGGTAAACATCTGCTC-3′.
The PCR products were electrophoresed and visualized
under ultraviolet light.
Ischemia/reperfusion (I/R) experiment
Nine rats were transferred with HIF/VP16, nine an-
imals were transferred with CAG/E-GFP, three ani-
mals were transferred with E-GFP/HIF-1a/K719T, while
three rats underwent mock transfer with Lipofectamine
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without plasmid. Forty-eight hours after gene transfer,
animals were anesthetized with sodium penotobarbital
intraperitoneally and were then subjected to bilateral
warm I/R injury by simultaneous clamping of both renal
pedicles for 45 minutes. During the ischemic phase, the
abdomen was partially closed and the surgical table tem-
perature was set at 39◦C as previously described [28].
At 6 hours of reperfusion, three animals from CAG/E-
GFP group and HIF/VP16 group each were sacrificed for
apoptosis evaluation while the remaining animals were
sacrificed at 48 hours.
Blood urea nitrogen (BUN) measurement
Blood samples were collected via tail veins just prior
to sacrifice. BUN was measured by (Wako Chemical) ac-
cording to the manufacturer’s protocol.
Immunocytochemistry
Three microns of paraffin-embedded, methyl Carnoy’s
fixed tissues were stepwise rehydrated. Endogenous per-
oxidase activity was quenched by incubation with 3%
H2O2 in PBS for 10 minutes. Nonspecific binding was
blocked with 4% skim milk and 1% bovine serum al-
bumin (BSA) in PBS and 0.1% Tween-20 for 30 minutes.
First antibodies were diluted in 1% BSA in PBS and 0.1%
Tween-20 at specific concentrations as described above,
and incubated for 1 hour at room temperature, followed
by incubation with suitable biotinylated secondary anti-
bodies. For HIF-1a and JG-12 staining, antigen retrieval
was carried out by autoclaving at 120◦C in 10 mmol/L
sodium citrate pH 6 for 20 minutes, the immunostain-
ing signal was amplified by tyramide signal amplification
(TSA) (Perkin-Elmer, Boston, MA, USA) according to
the manufacturer’s instruction. Avidin peroxidase was
applied at the final step, and color was developed with
3,3′ diaminobenzidine tetrahydrochloride (DAB) (Sigma
Chemical Co.) or DAB plus nickel [29]. Slides were exam-
ined by light microscopy (Olympus BX51, Tokyo, Japan),
and pictures were taken by Olympus DP12 system.
Detection of apoptotic cells
The terminal deoxynucleotidyl transferase (TdT) me-
diated nick-end labeling (TUNEL) method was used to
detect in situ DNA strand breaks. TACS 2 TdT-blue label
in situ apoptosis detection kit (Trevigen Inc., Gaithers-
burg, MD, USA) was used. Formaldehyde fixed paraffin
sections were deparaffinized, rehydrated, incubated with
proteinase K, and endogenous peroxidase activity was
quenched. The sections were then treated with biotiny-
lated nucleotide, manganese cation, and TdT enzyme.
After treating with streptavidin-horseradish peroxidase,
the sections were stained with blue label (or DAB plus
nickel). The tissues were counterstained with nuclear Fast
Red.
Immunoblotting analysis
Medullary tissues were homogenized in ice-cold ra-
dioimmunopreciptation assay (RIPA) buffer supple-
mented with 10 mmol/l phenylmethylsulfonyl fluoride
(PMSF), followed by centrifugation at 13000 rpm for
30 minutes. The supernatant was collected, and the pro-
tein concentration was measured by the Bradford protein
assay (Bio-Rad). Equal amounts of homogenate protein
(50 lg for nitrotyrosine and 120 lg for E-GFP) were sep-
arated in 10% sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) gel under reducing
conditions. The separated proteins were electrotrans-
ferred to a polyvinlydine difluoride (PVDF) membrane
(Amersham International, Buckingham, UK), and then
blotted with specific antibodies for 1 hour. After extensive
wash with Tris-buffered saline (TBS), the bound antibod-
ies were detected with alkaline phosphatase-conjugated
secondary antibody. 5-broma-4 chloro-3 indolyl phos-
phate/nitro blue tetrazolium tablets (SigmaFast) (Sigma
Chemical Co.) were used as a substrate. The represen-
tative blots were represented, while essentially the same
results were confirmed in three or four animals.
Semiquantitative scoring system
Scoring was done in a blinded manner. For E-GFP ex-
pression, 20 nonoverlapping fields at 200× magnification
from each rat were semiquantitatively scored according
to the following method: 0, no expression; 1, expression
of <10% of the examination field; 2, expression of 10%
to 25%; 3, expression of 26% to 50%; 4, expression of
51% to 75%; and 5, expression of >75% of the exami-
nation field. Histologic damage, composed of tubular ep-
ithelial injury, proteinacious cast, or tubular dilatation,
was scored on 15 to 20 randomly selected nonoverlapping
200× fields per rat on PAS according to the followings
scoring methods 0, no damage; 1, mild damage; 2, mod-
erate damage; and 3, severe damage [27]. Apoptotic cells
and infiltrating macrophages were counted on TUNEL
or ED1-positive cells on 10 to 15 randomly selected 200×
fields or entire specific area. HIF-1a–positive cells were
counted in the same manner.
The amount of peritubular capillaries was evaluated
by the vascular rarefaction index as previously described
[30].
Statistical analysis
All numerical data are presented as mean ± SD. One-
way analysis of variance (ANOVA) followed by the least
significant difference (LSD) method was used to deter-
mine differences more than two groups for all continuous
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Fig. 1. Expression of hypoxia-inducible
factor-1 (HIF-1a) in the renal medulla. Tyra-
mide amplification immunohistochemical
analysis of HIF-1a showed the expression
pattern in the medulla of normal rats. Low
levels of HIF-1a expression was found in
thin-wall tubules at the inner medulla (IM)
(A), and a few HIF-1a–positive cells were
also observed at the deep portion of the inner
stripe (IS) of the outer medulla. Notably
HIF–positive cells were likely to be found
one or two cells per tubular section. In
contrast, HIF-1a could not be detected at
the outer stripe (OS) of the outer medulla
(B). The medulla of CoCl2 treated rats
were serve as positive control for HIF-1 a
unlike normal expression, multiple tubular
cells were expressed HIF-1a simultaneously
(C). Thirty-six hours of water deprivation
increased HIF-1a signals at the inner medulla
(D) and the inner stripe (E). This up-
regulation at the inner medulla returned to
baseline after 4 hours with free access to wa-
ter (F). Quantitative analysis demonstrated
a dynamic up-regulation of HIF-1a at inner
medulla during dehydration-rehydration
(G).
parameters while Student t test was used for two-group
data. The Mann-Whitney test was applied for noncon-
tinuous parameters. The significance level was set at
P < 0.05 for all tests (SPSS for Windows 10.0) (SPSS,
Inc., Chicago, IL, USA).
RESULTS
A biologic role of HIF in the medulla of the
normal kidney
In order to investigate a role of HIF-1 in the normal
kidney, we detected HIF-1a by immunohistochemistry.
Expression of HIF-1a in the medulla of normal kid-
neys was relatively low with 7.7 ± 1.1 positive cells/field
(N = 5), and the expression was observed exclusively at
the deep portion of the inner stripe and the inner medulla
of normal rats (Fig. 1A and D). Most HIF-positive cells
were found in tubules with relatively thin walls, which we
speculated to be either the thin ascending or descending
limb of Henle. HIF-positive cells were mostly found only
as a single cell per tubule and resided distant from the
feeding plexus.
We also examined rats with water deprivation for 36
hours, because this increases medullary workload and de-
creases local blood flow [20]. Water-deprived rats showed
a marked increase of HIF-1a–positive cells at the inner
medulla to 20 ± 7.6 cells/field, or about 260% increase
(P < 0.05) (N = 5) (Fig. 1D and G). Moreover, HIF-1a
expression also extended to the superficial part of the in-
ner stripe (Fig. 1E). The number of HIF-1a–positive cells
rapidly deceased to 10.4 ± 1.2 cells/field after 4 hours
with free access to water (Fig. 1F and G), supporting in-
duction of HIF-1 activation by dehydration. To compare
expression of HIF-1a induced by dehydration, we also
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Fig. 2. Successful gene transfer of the kidney. (A) Fluorescent signal in medulla of kidney transferred with CAG/enhanced green fluorescent protein
(E-GFP). The strong expression of E-GFP was confirmed at the inner medulla and the inner stripe of gene-transferred kidneys was confirmed by
immunohistochemical analysis (B). In contrast, E-GFP was negative in contralateral kidneys which served as an internal control (C) In some E-GFP–
transferred animals, the expression of E-GFP was also observed in cortical tubules (D). A high magnification view showed that E-GFP–positive
cells in the medulla were tubules co-localizing with well-preserved vascular plexus (E). Semiquantitative scoring analysis demonstrated essentially
the same expression pattern of various control vectors in the kidney at tissue levels (F). Immunoblots of medullary tissues with anti-E-GFP showed
successful expression of E-GFP protein in these animals, while no expression was observed in their contralateral medulla (G).
performed experiments utilizing CoCl2, a chemical hy-
poxia mimic. We added CoCl2 to drinking water (2 mol/L)
for 10 days before sacrifice as previously described [27]
(Fig. 1C). Induction of HIF-1a by cobalt was comparable
to that by water deprivation.
Distribution of the transgene products in the kidney
In order to further elucidate a functional role of HIF-1
in the kidney, we employed a technique of gene trans-
fer [26]. As the first step of the experiments, we investi-
gated efficiency of the gene transfer and localization of
the transgene products with an E-GFP expressing vec-
tor under the ubiquitous promoter, designated as CAG/
E-GFP.
All animals survived the procedure of gene trans-
fer. Histologic examination on PAS staining at 48 hours
showed mild and nonspecific damage in the medullary
tubules. The fluorescent signals of E-GFP were detected
in the medulla at this time point (Fig. 2A). To confirm and
quantify this result, immunohistochemical studies were
performed with E-GFP specific antibody, which clearly
showed the transgene products in the kidney of all the
experimental animals (N = 10). In our preliminary ex-
periments, the expression was observed as early as at 24
hours and remained detectable for more than 5 days (data
not shown). Expression of the transgene products was al-
ways observed prominently at the inner medulla and the
inner stripe (Fig. 2B and E), while we did not detect any
signals in the contralateral kidney (Fig. 2C). Immunoblots
of medullary tissues confirmed these results (Fig. 2G). In
some animals, expression of the transgene was also found
in a few cortical tubules (Fig. 2D). Quantitative analysis
confirmed the prominent and reproducible expression
of the transgene at the inner medulla and inner stripe
(Fig. 2F).These results ensured us an efficient transfer of
our vectors at the inner medulla and the inner stripe by
our method.
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Fig. 3. Tubulointerstitial damage induced by negative-dominant hypoxia-inducible factor (HIF) (HIF 1-330). Periodic acid-Schiff (PAS) examina-
tion after 48 hours of gene transfer showed minimal tubular damage with well-persevered capillary plexus in kidneys treated with a control vector
[enhanced green fluorescent protein (E-GFP)/HIF-1a/K719T] (A). In contrast, histologic examination of HIF 1-330 transferred kidneys showed
severe damage (B). Immunohistochemical studies of vascular endothelial growth factor (VEGF) showed prominent expression of VEGF in kidneys
treated with nonfunctional vectors (C) while expression of tubular VEGF decreased and was scattered in the damaged area of negative-dominant
HIF-transferred kidneys (D). Staining of JG-12 of kidneys treated with negative HIF 1-330 showed the disaggregated vascular network (white
asterisk) (E). Terminal deoxynucleotidyl transferase (TdT) mediated nick-end labeling (TUNEL) analysis combined with JG-12 showed apop-
totic endothelial cells in HIF 1-330 transferred kidneys (F). Vascular rarefaction index confirmed capillary regression in negative-dominant HIF
transferred kidneys (G).
Medullary damage after negative-dominant HIF
gene transfer
Next we investigated a role of HIF in the normal
medulla. Ten animals were transferred with the plasmid
encoding the first 330 AA (bHLH and PAS domain) of
human HIF-1a which functions as a negative-dominant
vector, HIF-1-330, while six animals were transferred
with a control plasmid, E-GFP/HIF-1a/K719T, which has
a targeted mutation in the NLS motif and cannot enter
the nucleus. Forty-eight hours after gene transfer, kidneys
were removed. On gross examination, four of ten ani-
mals lost papilla and three animals developed interstitial
hemorrhage in the medulla. In contrast, no gross patho-
logic changes were observed in the control E-GFP/HIF-
1a/K719T transfected animals (Fig. 3A). Since the control
E-GFP/HIF-1a/K719T might possibly interfere with HIF
pathway, for example, saturation of prolyl hydroxylase
enzyme, another control vectors CAG/E-GFP, or consti-
tutively active HIF/VP16 (N = 30 in total) were evaluated
together. Again none of those additional vectors pro-
duced damages as observed in negative-dominant HIF.
These results supported our observation that the renal
damage was specific to down-activation of HIF. Micro-
scopic examination revealed tubulointerstitial damage in
the medulla of rats transfected with negative-dominant
HIF, which involved the capillary networks (Fig. 3B).
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Fig. 4. Stimulation of hypoxia-inducible factor (HIF) regulated genes in the medulla by HIF/VP16. The expression of HIF/VP16 gene in kidney
was confirmed by reverse transcription-polymerase chain reaction (RT-PCR) (A) (representative picture from three animals). Significant increases
of HIF-1 regulated genes were detected after 48 hours of HIF/VP16 gene transfer (B). Periodic acid-Schiff (PAS) staining of HIF/VP16 transferred
kidneys showed minimal tubulointerstitial damage (C), comparable to the control plasmids transferred kidney (see Figure 3A). Immunohisto-
chemical studies of JG-12, after 48 hours of transfection of HIF/VP16 (D) and CAG/enhanced green fluorescent protein (E-GFP) (E), showed a
comparable, well-formed capillary plexus without damage in both groups.
Immunohistochemical analysis of VEGF showed a de-
crease in tubular VEGF in the damaged areas (Fig. 3D),
while tubular VEGF was well maintained in the control
gene transferred kidneys (Fig. 3C). Immunohistochemi-
cal analysis of JG-12, a marker of rat endothelial cells [30],
showed disruption of the capillary plexus in the medulla
of negative-dominant HIF-treated rats (Fig. 3E). TUNEL
assays detected apoptotic cells (9 to 15 cells/section), and
when we combined TUNEL with immunodetection of
JG-12, about 50% of TUNEL-positive cells were found in
the capillaries, suggesting endothelial apoptosis (Fig. 3F).
The regression of the capillary network was confirmed by
capillary rarefaction index (Fig. 3G), which significantly
increased in HIF-1-330 transferred kidneys compared to
that of the control transferred and normal kidneys (P <
0.05).
HIF/VP16 increased expression of a variety
of HIF-regulated genes in the medulla
Next, we delivered the HIF/VP16 expression vector
into eight rats. The transgene product is resistant against
degradation due to lack of the oxygen dependence degra-
dation domain and becomes constitutively active. Prod-
ucts of the chimeric gene in medulla were detected by
reverse transcription (RT)-PCR at 48 hours after admin-
istration of the vector in all the gene transferred kidneys
but not in the contralateral kidneys (Fig. 4A).
In order to confirm functional consequences of gene
transfer of this vector, we examined gene expression pro-
files of HIF-regulated genes by quantitative real-time RT-
PCR. At 48 hours after the gene transfer, we observed a
marked increase in HIF-regulated genes in the medulla,
including VEGF, HO-1, EPO, and GLUT-1 (Fig. 4B).
On gross pathologic examination, medullas of HIF-1/
VP16 transferred kidney were well preserved. Micro-
scopic examination did not detect tubulointerstitial dam-
age (Fig. 4C). Immunohistochemical staining of JG-12
showed capillary plexus without damage in the HIF/VP16
transferred kidneys, which were comparable to the con-
trol (Fig. 4D and E).
HIF-1 activation protected the kidney against
ischemic insult
Next, we investigated a protective role of activation
of HIF-1 in the medulla against ischemic injury. In our
experimental conditions, difference of BUN at 6 hours
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between HIF-1 activated animals and control rats did not
reach statistical significance (42.3 ± 16.3 mg/dL vs. 51.8 ±
8.13 mg/dL). No mortality was observed within the first
12 hours after the ischemic insult. However, three of
six animals in CAG/E-GFP, one of three E-GFP/HIF-
1a/K719T transferred rats, one of three mock transfected
rats treated with Lipofectamine without plasmids, and
one of six HIF/VP16 administered animals died between
12 and 30 hours. BUN levels of the surviving CAG/E-
GFP, E-GFP/HIF-1a/K719T, and mock transferred ani-
mals were significantly higher (207.7 ± 86.7 mg/dL, 182 ±
9.9 mg/dL, and 157.2±68.4 mg/dL, respectively) than that
of the surviving HIF/VP16 transferred animals (76.1 ±
48.6 mg/dL) (P < 0.05).
Histologic analysis revealed attenuation of ischemic
injury by HIF-1 activation
Histologic examinations of CAG/E-GFP transferred
kidneys showed severe tubular necrosis (Fig. 5A). In
contralateral kidneys from HIF/VP16 and E-GFP trans-
ferred animals the severity of kidney injury was equiv-
alent. In contrast, the damage in HIF/VP16 transferred
kidneys was subtle, suggesting a protective role of HIF-
1 activation (Fig. 5B). Semiquantitative analysis con-
firmed improvement of the kidney injury by HIF-1 ac-
tivation (Fig. 5C). Immunohistochemical studies of ED1,
a maker of rat macrophage, showed a significant decrease
in macrophage infiltration in HIF/VP16 transferred kid-
neys compared to CAG/E-GFP controls (Fig. 5D). As
expected, medullary JG-12 expression was preserved
in HIF/VP16 transferred kidneys compared to control
gene transferred kidneys and contralateral control kid-
neys. Capillary rarefaction index showed preservation of
the capillary network in HIF/VP16 transferred kidneys
(Fig. 5E).
HIF-1 activation ameliorated oxidative stress
and apoptosis in the ischemic medulla
To investigate protective mechanisms of HIF-1 activa-
tion, we studied apoptosis and oxidative stress which are
important pathogenic factors in ischemic injuries. At 6
hours, apoptotic cells were found scattering throughout
the medulla of CAG/E-GFP transferred kidneys and con-
tralateral control kidneys at a similar degree (Fig. 6A).
In contrast, HIF-1 activation significantly decreased the
number of apoptotic cells (Fig. 6B). The number of apop-
totic cells at the inner stripe of control gene transferred
kidneys and that of the contralateral kidneys were 16.6 ±
5.1 cells/field and 15.9 ± 5.0 cells/field, respectively. In
contrast, the number of apoptotic cells decreased to 5.8 ±
3.5 cells/field in HIF/VP16 transferred kidneys (P < 0.05)
(Fig. 6C), while that of the contralateral kidneys were
16.7 ± 6.1 cells/field. Immunoblotting analysis of ni-
trotyrosine, a marker of oxidative stress [28], revealed a
marked decrease of tissue nitrotyrosine at 48 hours in the
medulla of HIF/VP16 transferred kidneys compared to
contralateral control and control plasmid transferred kid-
neys (Fig. 6D), suggesting that protective mechanism(s)
might take part by decreasing oxidative damage.
DISCUSSION
In the first part of this work, we detected HIF-1a in
the medulla by the immunohistochemical method. The
amount of HIF-1a in the medulla was relatively low, but
its constitutional expression at the inner medulla was ob-
served, where tissue oxygen tension is the lowest [17,
21]. In contrast, HIF-1a could not be detected in cor-
tical tubules where tissue oxygen tension is maintained
higher. This is not surprising because oxygen tensions
in the renal cortex are generally higher with an average
pO2 of around 30 to 50 mm Hg, compared with those
in the renal medulla, which are continuously below 10
mm Hg. The reasons for the difference in oxygenation
are multifactorial. Renal blood flow is directed mostly
to the cortex to optimize glomerular filtration and the
reabsorption of solute. By contrast, blood flow to the
renal medulla is low to preserve osmotic gradients and
enhance urinary concentration [17]. Within the medulla,
tubules and vasa recta are disposed in a hairpin pattern
to maximize the concentration of urine by countercur-
rent exchange. Oxygen diffusion from arterial to venous
vasa recta also leaves the medulla deficient in oxygen.
Because of these anatomic and functional aspects, re-
nal corticomedullary differential oxygen tension has been
speculated as a crucial factor for kidney to adjust EPO
production rate in balance with salt and water reabsorp-
tion [33]. Nuclear localization of HIF-1a suggested that
we detected an active from of HIF-1a. The expression
of HIF-1a in medulla has been reported by Stroka et al
[34] and Yuan et al [35]. The latter work also suggested
that HIF-1a may exert its role on peritubular capillary of
the kidney. In contrast to our results and others, Rosen-
berger et al [36] could not detect HIF-1a in this area of
normal rats. This disparity may be explained by the dif-
ference of antigen retrieval techniques and microscopic
methodology. In addition, Zou et al [37] showed HIF-1a
protein in the medulla by chemiluminescence-based im-
munoblotting analysis. Of note, they showed a decrease
of medullary HIF-1a after administration of furosemide,
which is well known to decrease medullary workload and
improves oxygenation. In this study, we confirmed and
extended their results, showing an increase of HIF-1a
during dehydration.
In case of dehydration, workload in the medulla is in-
creased because the kidney must concentrate urine. In-
creased medullary workload is known to decrease local
oxygen concentrations [17]. Furthermore, previous stud-
ies showed a decrease in medullary blood flow in case
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Fig. 5. Hypoxia-inducible factor-1 (HIF-1) activation protected the medulla against ischemia. High magnification of periodic acid-Schiff (PAS)
staining of CAG/enhanced green fluorescent protein (E-GFP) transferred kidneys at 48 hours of reperfusion showed severe tubular damage in
the medulla (A). In contrast, tubular damage of HIF/VP16 transferred kidneys was significantly milder (B). Semiquantitative histologic analysis
confirmed less histological damage in the kidney of HIF/VP16 transfer (C). ∗P < 0.05 compared to control. Quantitative analysis of immunohisto-
chemical studies of ED1 at 48 hours after ischemia showed less macrophage infiltration in HIF/VP16 transferred kidneys (D). ∗P < 0.05 compared
to control. Peritubular capillary loss was evaluated on capillary rarefaction of JG-12 which was significantly higher in CAG/E-GFP transferred
kidneys and contralateral kidneys from both groups (E).
of dehydration [20]. It is likely that low tissue oxygen in-
duced by an increase of workload and a decrease in blood
flow stimulated accumulation of HIF-1a during dehydra-
tion. Living on the terrene, animals are not allowed to
drink water at every desirable time. Various degrees of
dehydration always occur in life, and water conservation
is a key for this life. Our results suggested a physiologic
role of HIF-1 in the medulla in post-natal life.
To further elucidate a biological role of HIF-1 in the
medulla, we employed a gene transfer technique. Trans-
fer of negative dominant HIF caused severe medullary
damage, accompanied by a decrease in tubular VEGF
Manotham et al: A biologic role of HIF-1 in the renal medulla 1437
0
100
200
300
400
Ce
lls
/fi
el
d
Inn
er
m
ed
ulla In
ne
r
str
ipe Ou
ter
str
ipe
CAG/E-GFP
Contralateral EGFP
Contralateral
HIF/VP16
HIF/VP16
Macrophage infiltrationD
*
* *
0
10
20
30
40
50
60
70
%
CAG/E-GFP HIF-VP16
Gene transferred
kidney
Contralateral
E Capillary rarefaction
*
Fig. 5. (continued.)
A B
C Apoptotic cell
0
5
10
15
20
25
Ce
lls
/fi
el
d
Inn
er
m
ed
ulla In
ne
r
str
ipe Ou
ter
str
ipe
CAG/E-GFP
Contralateral
E-GFP
Contralateral
HIF/VP16
HIF/VP16
*
* *
D
HIF
/VP
16
Co
ntr
ala
ter
al 
HIF
/VP
16
HIF
/VP
16
Co
ntr
ala
ter
al 
HIF
/VP
16
E-G
FP
Co
ntr
ala
ter
al 
EG
FP
Fig. 6. A decrease in apoptotic cells and tissue nitrotyrosine in HIF-1 activated kidneys. Terminal deoxynucleotidyl transferase (TdT) mediated
nick-end labeling (TUNEL) assays of CAG/enhanced green fluorescent protein (E-GFP) (A) and HIF/VP16 (B) transferred kidneys at 6 hours
after ischemia showed a significant decrease in TUNEL-positive cells in the medulla by HIF/VP16 transfer (C). ∗P < 0.05 compared to control.
Immunoblotting analysis of tissue nitrotyrosine (D) showed significantly lower oxidative stress in HIF/VP16 kidneys (lanes 1 and 3, compared to
matched contralateral kidneys; lanes 2 and 4, control plasmid transfer; lane 5, and its contralateral kidney; lane 6).
at corresponding tubules. TUNEL studies suggested that
significant endothelial apoptosis occurred at the inner
medulla. Interestingly similar pathologic changes were
reported in Cre-loxP targeting VEGF mice after turn-
off of VEGF [38]. Moreover, accumulating evidence ad-
dressed a crucial role of tubular VEGF on maintenance
of peritubular capillary networks [30, 35, 39, 40]. Taken
together with our results, we speculated that continuous
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activation of HIF-1 is involved in maintaining the unusu-
ally dense capillary plexus of the medulla at least in part
via VEGF. Beside VEGF, HIF also regulates several en-
dothelial survival factors, including adrenomedullin [41,
42], platelet-derived growth factor (PDGF) [43], and an-
giopoietin [44], which may participate in capillary main-
tenance as well. It should be noted that another oxygen-
regulated molecule, HIF-2a, which is also known as HLF
(HIF-1a–like factor) and shares common structures and
functions with HIF-1a, is also found in the kidney [35].
However, recent studies showed that accumulation of
HIF-1a and HIF-2a is selective with respect to cell type,
and that HIF-2a is not expressed in tubular cells [36].
Recent studies emphasized a role of HIF-2a in EPO reg-
ulation [36, 45]. Recently, data from HIF-2a knockout an-
imals showed multi organs damage, marrow failure and
anemia, but minimal renal damage suggested that HIF-2a
may not involve, or be compensated by HIF-1a, in main-
taining renal vascular architectures [46, 47]. In addition
to the HIF system, the expression of hypoxia-inducible
genes may rely on normoxic repressors, too. For example,
the transcription of EPO is activated by HIF but is inhib-
ited by GATA-2. In normoxic environment where HIF
is inactivated, GATA-2 strongly binds to 5′ promoter of
EPO gene; thus inhibiting EPO transcription [48]. In hy-
poxia, heterodimer of HIF binds to 3′ enhancer while, by
an unknown mechanism(s), GATA-2 decreases its bind-
ing activity, resulting EPO transcription [49].
Next we investigated effects of constitutive activation
of HIF-1 in the medulla. For this purpose, we employed a
constitutively active HIF/VP16 chimeric vector [24, 31,
32]. At 48 hours after HIF/VP16 transfer, expression
of HIF-regulated genes, including HO-1, VEGF, EPO,
and GLUT-1, increased significantly compared to gene
transfer of control vectors. All these genes have previ-
ously been reported to have a protective role against
ischemic damages [27, 50–52]. Continuous activation of
HIF with HIF/VP16 gene transfer revealed protective ef-
fect(s) against ischemic injury, including decreased apop-
tosis, decreased macrophage infiltration, amelioration of
oxidative stress, preservation of the medullary vascula-
ture, and improvement of histologic damages. The net
protective results were reflected by preservation of re-
nal function and low mortality in the HIF/VP16-treated
animals. Mortality was relatively high in groups treated
with control vectors compared with previous reports em-
ploying the same model [27], and we speculate that this
was because our experimental animals had to undergo
two consecutive surgical procedures, gene transfer and
ischemic insult. These results strongly supported a role
of HIF-1 activation in protection against ischemia in the
medulla. However, the positive results in our work on
HIV/VP16 should not be overstated. Some recent works
showed unwanted effects of HIF activation, including in-
duction of apoptosis [53], fibrosis [5, 54], and unregulated
cell proliferation [55]. Though most of those data came
from in vitro studies, therapeutics approaches targeting
HIF require further warrant.
CONCLUSION
We reported constitutional activation of HIF-1 in the
medulla, which is increased by dehydration. HIF-1 pro-
tects the medulla itself under normal physiologic condi-
tions and against hypoxic damages, playing a crucial role
in maintaining medullary architecture.
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